Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Gordon

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|January 1, 1988
Amikacin pharmacokinetics in patients with spinal cord injuryJ L Segal, S R Brunnemann, S K Gordon, et al.
Paraplegia|August 1, 1988
Non-traumatic ischaemic myelopathy: a review of 25 casesS W Kim, R C Kim, B H Choi, et al.
Clinical Pharmacy|July 1, 1985
Theophylline pharmacokinetics in paraplegic subjectsJ L Segal, C M Smith, S K Gordon, et al.
American Corrective Therapy Journal|November 1, 1980
Uechi-Ryu karate in spinal cord injury rehabilitation: the Sepulveda experienceS K Gordon, A Scalise, R M Felton, et al.
Pharmacotherapy|January 1, 1986
The absolute bioavailability of oral theophylline in patients with spinal cord injuryJ L Segal, S R Brunnemann, S K Gordon, et al.
The Journal of the American Paraplegia Society|October 1, 1992
Drug use and abuse in an urban veteran spinal cord injured populationJ L Rothstein, E Levy, R Fecher, et al.
Clinical Pharmacy|July 1, 1984
Pharmacokinetics of gentamicin in patients with spinal cord injuryJ L Segal, D R Gray, S K Gordon, et al.
Applied Optics|March 10, 2010
Optical transfer function synthesis: a geometrical optics approachH H Barrett, M Y Chiu, S K Gordon, et al.
The Journal of the American Paraplegia Society|April 1, 1983
Gentamicin disposition kinetics in humans with spinal cord injury: a preliminary reportJ L Segal, D R Gray, S K Gordon, et al.
Cancer Research|September 15, 1987
Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyreneD K Manchester, S K Gordon, C L Golas, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|January 1, 1988
Amikacin pharmacokinetics in patients with spinal cord injuryJ L Segal, S R Brunnemann, S K Gordon, et al.
Paraplegia|August 1, 1988
Non-traumatic ischaemic myelopathy: a review of 25 casesS W Kim, R C Kim, B H Choi, et al.
Clinical Pharmacy|July 1, 1985
Theophylline pharmacokinetics in paraplegic subjectsJ L Segal, C M Smith, S K Gordon, et al.
American Corrective Therapy Journal|November 1, 1980
Uechi-Ryu karate in spinal cord injury rehabilitation: the Sepulveda experienceS K Gordon, A Scalise, R M Felton, et al.
Pharmacotherapy|January 1, 1986
The absolute bioavailability of oral theophylline in patients with spinal cord injuryJ L Segal, S R Brunnemann, S K Gordon, et al.
The Journal of the American Paraplegia Society|October 1, 1992
Drug use and abuse in an urban veteran spinal cord injured populationJ L Rothstein, E Levy, R Fecher, et al.
Clinical Pharmacy|July 1, 1984
Pharmacokinetics of gentamicin in patients with spinal cord injuryJ L Segal, D R Gray, S K Gordon, et al.
Applied Optics|March 10, 2010
Optical transfer function synthesis: a geometrical optics approachH H Barrett, M Y Chiu, S K Gordon, et al.
The Journal of the American Paraplegia Society|April 1, 1983
Gentamicin disposition kinetics in humans with spinal cord injury: a preliminary reportJ L Segal, D R Gray, S K Gordon, et al.
Cancer Research|September 15, 1987
Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyreneD K Manchester, S K Gordon, C L Golas, et al.
Pageof 3